Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:navy;" |'''κ/λ''' | |colspan="1" style = "font-size:90%; color:navy;" |'''κ/λ''' | ||
|colspan="1" style = "background:#00b8e6;"|40:60% (wk) | |colspan="1" style = "background:#00b8e6;color:black"|40:60% (wk) | ||
|colspan="1" style = "width: 8%; background:#004466;"|>80% | |colspan="1" style = "width: 8%; background:#004466;color:white;"|>80% | ||
|colspan="1" style = "width: 8%; background:#006699;"|60:80& | |colspan="1" style = "width: 8%; background:#006699;color:white;"|60:80& | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:navy;" |'''FMC7''' | |colspan="1" style = "font-size:90%; color:navy;" |'''FMC7''' | ||
Revision as of 17:29, 21 June 2023
| Immunophenotype LPD | |||
|---|---|---|---|
| Marker | CLL | MCL | FL |
| κ/λ | 40:60% (wk) | >80% | 60:80& |
| FMC7 | |||
| CD5 | |||
| CD10 | |||
| CD11C | |||
| CD19 | |||
| CD20 | |||
| CD23 | |||
| CD25 | wk | ||
| CD38 | |||
| CD43 | |||
| CD79a | wk | ||
| CD103 | |||
| CD138 | |||
| CD200 | |||
Key to table:
Key to colour code Click for link
Key to expression code Click for link